Logo

Progenika

Progenika Biopharma Lands CE Mark for NGS Familial Hypercholesterolemia Test

The firm's Seqpro Lipo IS is the first approved NGS diagnostic assay for the disease, which affects one in 300 people.

Grifols Gains CE-IVD Mark for Progenika ID Core XT Kit for Molecular Blood Group Typing
Premium

NEW YORK (GenomeWeb) – Grifols has garnered a CE-IVD mark for ID Core XT, a bead array-based assay for molecular blood group typing, the company said this week.

Progenika CEO Sees No 'Major Impact' After Grifols Acquires Majority Stake in Firm
Premium

Spanish genetic testing firm Progenika Biopharma will continue to pursue its business objectives after Barcelona-based plasma products manufacturer Grifols acquired a 60 percent stake in the firm for for €37 million ($48.4 million), according to its CEO.

Genetic Analysis, with New CEO at the Helm, Aims to Have IBS Test CE-IVD Marked This Year
Premium

Norwegian molecular diagnostics firm Genetic Analysis announced two new developments last week. The first was the appointment of Kari Stenerson, a former Axis-Shield marketing director, as its new CEO.

Progenika Gets CAP Accreditation for Lab

NEW YORK (GenomeWeb News) – Progenika this week said that its CLIA laboratory has received accreditation from the College of American Pathologists. The Medford, Mass.-based firm provides blood group genotyping services to blood banks and hospitals in the US and Canada.